MeritValue

Electromedical Technologies, Inc

EMEDdata completeness 100%5 fiscal years on file

Data notes: no data for concept 'incomeTaxExpense'; no data for concept 'pretaxIncome'

i. The business — what you’d actually own
FigureFY 2019FY 2020FY 2021FY 2022FY 2023
Revenue$829,7371$737,9582$907,3623$1.15M4$1.35M4
Net income−$1.74M5−$3.87M6−$8.48M7−$3.47M8−$2.64M8
Operating cash flow−$280,7729−$1.34M10−$1.19M11−$773,33712−$1.42M12
Capital expenditure————$149,70513
Free cash flow (derived)————−$1.57M12
Total debt—$732,26614$702,78015$671,52516$150,00017
Cash & equivalents$018$264,91319$383,17020$368,42521$87,70421
Diluted shares17.9M22.3M51.0M133.6M377.2M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0.08
your share of equity
Profit it earned you last year
−$0.07
Free cash flow it threw off
−$0.04
Debt you’d be carrying
$0

10 shares is a claim on −$0.08 of net worth that earned you −$0.07 and generated −$0.04 of cash last year, against $0 of debt.

iii. Is this a good business?
Moat signal · return on equity
— avg · 5y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
+2007% shares · 5y

Share count is up 2007% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has fallen 80% — deleveraging.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
only 1 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 1 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2019-12-31 · accession 0001104659-21-043965 (RevenueFromContractWithCustomerExcludingAssessedTax)
  2. 10-K · period ending 2020-12-31 · accession 0001410578-22-000752 (RevenueFromContractWithCustomerExcludingAssessedTax)
  3. 10-K · period ending 2021-12-31 · accession 0001410578-23-000555 (RevenueFromContractWithCustomerExcludingAssessedTax)
  4. 10-K · period ending 2022-12-31 · accession 0001410578-24-000581 (RevenueFromContractWithCustomerExcludingAssessedTax)
  5. 10-K · period ending 2019-12-31 · accession 0001104659-21-043965 (NetIncomeLoss)
  6. 10-K · period ending 2020-12-31 · accession 0001410578-22-000752 (NetIncomeLoss)
  7. 10-K · period ending 2021-12-31 · accession 0001410578-23-000555 (NetIncomeLoss)
  8. 10-K · period ending 2022-12-31 · accession 0001410578-24-000581 (NetIncomeLoss)
  9. 10-K · period ending 2019-12-31 · accession 0001104659-21-043965 (NetCashProvidedByUsedInOperatingActivities)
  10. 10-K · period ending 2020-12-31 · accession 0001410578-22-000752 (NetCashProvidedByUsedInOperatingActivities)
  11. 10-K · period ending 2021-12-31 · accession 0001410578-23-000555 (NetCashProvidedByUsedInOperatingActivities)
  12. 10-K · period ending 2022-12-31 · accession 0001410578-24-000581 (NetCashProvidedByUsedInOperatingActivities)
  13. 10-K · period ending 2023-12-31 · accession 0001410578-24-000581 (PaymentsToAcquirePropertyPlantAndEquipment)
  14. 10-K · period ending 2020-12-31 · accession 0001104659-21-043965 (LongTermDebt)
  15. 10-K · period ending 2021-12-31 · accession 0001410578-22-000752 (LongTermDebt)
  16. 10-K · period ending 2022-12-31 · accession 0001410578-23-000555 (LongTermDebt)
  17. 10-K · period ending 2023-12-31 · accession 0001410578-24-000581 (LongTermDebt)
  18. 10-K · period ending 2019-12-31 · accession 0001104659-21-043965 (CashAndCashEquivalentsAtCarryingValue)
  19. 10-K · period ending 2020-12-31 · accession 0001410578-22-000752 (CashAndCashEquivalentsAtCarryingValue)
  20. 10-K · period ending 2021-12-31 · accession 0001410578-23-000555 (CashAndCashEquivalentsAtCarryingValue)
  21. 10-K · period ending 2022-12-31 · accession 0001410578-24-000581 (CashAndCashEquivalentsAtCarryingValue)